Last Price Today's Change   Day's Range   Trading Volume
0.10   +0.005 (5.26%)  0.085 - 0.105  378,271


Avg Volume (4 weeks):123,287
4 Weeks Range:0.085 - 0.125
4 Weeks Price Volatility (%):
52 Weeks Range:0.085 - 0.27
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

AdAlta Limited is an Australia-based drug discovery and development company. The Company is focused on using its technology platform to generate protein therapeutics, known as i-bodies, for treating a range of human diseases. The Company's principal activity is to develop its ibody platform with a focus on its lead candidate AD-114, a treatment for idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases. Its i-body AD-114 drug candidate is used for treatment in various fibrosis related eye diseases to support the pre-clinical development of the eye fibrosis indication. The Company's AD-114 has shown both anti-fibrotic and anti-inflammatory effects in various animal models. The Company's AD-114 is used in various therapeutic applications for fibrosis diseases of the liver, skin, kidney and heart. AD-114 has completed pre-clinical studies in vitro (in the lab) and in vivo (in animals) data obtained.

  Be the first to like this.


562  619  626  2491 

Top 10 Active Counters
 CLZ 0.0030.00 
 IMU 0.031-0.002 
 TLS 3.77+0.06 
 NWE 0.0040.00 
 S32 2.79+0.08 
 BLK 0.0120.00 
 PWN 0.008-0.002 
 NEC 1.820.00 
 LEG 0.085+0.01 
 NHL 0.0540.00 
Partners & Brokers